Neuromediators of Immunity and Inflammation

  • E. J. Goetzl
  • C. W. Turck
  • K. E. Peterson
  • R. J. Finch
  • K. T. Kodama
  • D. C. Adelman
  • S. P. Sreedharan
Conference paper


The nature and extent of the alterations in immunity resulting from neural lesions, and of the neural adaptation to immune reactions and inflammation suggested initially that the two systems cooperate in host defense (Ader 1981; Goetzl & Spector 1989). The elucidation of patterns of innervation of organs of the immune system, effects of immune cytokines on neuroendocrine functions, and mechanisms of response of immune cells to neuromediators has provided models and techniques for molecular and cellular studies of neuroendocrine interactions (Goetzl and Spector 1989). The findings of similar membrane protein antigens, enzymatic pathways, mediators, and receptors in some neuroendocrine and immune cells supported further the evolving concept of a multisystem network. A conceptual integration of currently available data suggests that some distinct phases of immunity and inflammation are particularly susceptible to neural influences. The potency and specificity of neuropeptide mediators in chronic immunological reactions, involving predominantly macrophages and lymphocytes, will be described as the background for discussion of recent studies of immune variants of some neuropeptides and the corresponding lymphocyte receptors.


Mast Cell Nerve Growth Factor U266 Cell Lymphocyte Receptor Neuroendocrine Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahmed SA, Dauphinee MJ, Montoya AI, Talal N. (1989) J Immunol 142:2647–2653Google Scholar
  2. Bernton EW, Meitzer MS (1988) Science 239:401–404PubMedCrossRefGoogle Scholar
  3. Cannon JG, Tatro JB, Reichlin S, Dinarello CA (1986) J Immunol 137:2232–2236PubMedGoogle Scholar
  4. Edwards CK, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW (1988) Science 239:769–771PubMedCrossRefGoogle Scholar
  5. Finch RJ, Sreedharan SP, Goetzl EJ. (1989) J Immunol 142:1977–1981PubMedGoogle Scholar
  6. Foreman JC, Jordan CC, Oehme P, Renner H (1983) J Physiol 335:449–465PubMedCentralPubMedGoogle Scholar
  7. Goetzl EJ, Kodama KT, Turck CW, Schiogolev SA, Sreedharan SP (1989a) Immunol 66:554–558Google Scholar
  8. Goetzl EJ, Payan DG (1984) J Immunol 133:3255–3259PubMedGoogle Scholar
  9. Goetzl EJ, Sreedharan SP, Turck CW (1988) J Biol Chem 263:9083–9086PubMedGoogle Scholar
  10. Goetzl EJ, Turck CW, Sreedharan SP. (1989b in press) Production and recognition of neuropeptides by cells of the immune system. In: Ader R, Feiten DL, Cohen N (eds) Psychoneuroimmunology — II. Academic Press, New YorkGoogle Scholar
  11. Goetzl EJ, Spector NH (eds) (1989 in press) Neuroimmune networks: Physiology and diseases. Alan R Liss Inc., New YorkGoogle Scholar
  12. Kimball ES, Persico FJ, Vaught JL (1988) J Immunol 141:3 564–3569Google Scholar
  13. Levine JD, Goetzl EJ, Basbaum AI (1987) Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. In: Zvaifler NJ (ed) Rheumatic disease clinics of North America, vol 13, no 3. W B Saunders Co, Philadelphia London Toronto Montreal Sydney Tokyo, p 369Google Scholar
  14. Martin J, Prystowsky MB, Angeletti RH (1987) J of Neurosci Res (1987) 18:82–87CrossRefGoogle Scholar
  15. Mason MJ, Van Epps D (1989) J. Immunol 142:1646–1651PubMedGoogle Scholar
  16. LeMaire I (1988) J Immunol 140:2983–2988Google Scholar
  17. Lötz M, Vaugh JH, Carson DA (1988) Science 241:1218–1221PubMedCrossRefGoogle Scholar
  18. Nong YH, Titus RG, Ribeiro JM, Remold HG (1989) 143:45–49Google Scholar
  19. O’Dorisio MS, Tseng J (1989 in press) Mechanisms of VIP-mediated immunoregulation. In: Goetzl EJ, Spector NH (eds) Neuroimmune networks: Physiology and diseases. Alan R Liss Ine, New YorkGoogle Scholar
  20. Perianin A, Snyderman R, Malfroy B (in press) Biochem Biophys Res CommunGoogle Scholar
  21. Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987) J Immunol 138:3907–3912PubMedGoogle Scholar
  22. Ruff MR, Wahl SM, Mergenhagen S, Pert CB (1985) Neuropeptides 5:363–366PubMedCrossRefGoogle Scholar
  23. Scicchitano R, Bienenstock J, Stanisz AM (1988) Immunol 63:733–735Google Scholar
  24. Screpanti I, Morrone S, Meco D, Santoni A, Gulino A, Paolini R, Crisanti A, Mathieson BJ, Frati L. (1989) J Immunol 142:3378–3383PubMedGoogle Scholar
  25. Serra MC, Bazzoni F, Bianca VD, Greskowiak M, Rossi F (1988) J Biol Chem 141:2118–2124Google Scholar
  26. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ (1989a) J Biol Chem 264:949–952PubMedGoogle Scholar
  27. Sreedharan SP, Peterson KE, Kodama KT, Finch RJ, Taraboulos A., Serwonska MH, Goetzl EJ (1989 in press) Generation and recognition of neuropeptide mediators of cellular communication in immunity and hypersensitivity. IN: Goetzl EJ, Spector NH (eds) Neuroimmune networks: Physiology and disease. Alan R Liss Inc, New YorkGoogle Scholar
  28. Tomioka M, Stead RH, Nielsen L, Coughlin MD, Bienenstock J (1988) J Allergy Clin Immunol 82:599–607PubMedCrossRefGoogle Scholar
  29. Torres BA, Johnson HM (1988) J Immunol 140:2179–2183PubMedGoogle Scholar
  30. Weinstock JV, Blum A, Walder J, Walder R (1988) J Immunol 141:961–966PubMedGoogle Scholar
  31. Williamson SA, Knight RA, Lightman SL, Hobbs JR (1988) Immunol 65:47–51Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • E. J. Goetzl
  • C. W. Turck
  • K. E. Peterson
  • R. J. Finch
  • K. T. Kodama
  • D. C. Adelman
  • S. P. Sreedharan

There are no affiliations available

Personalised recommendations